LENZ Therapeutics, Inc. — Director's Dealing 2021

Jun 25, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Graphite Bio, Inc. (GRPH)
CIK: 0001815776
Period of Report: 2021-06-24

Reporting Person: Samsara BioCapital, L.P. (10% Owner)
Reporting Person: 436, L.P. (10% Owner)
Reporting Person: AKKARAJU SRINIVAS (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Redeemable Convertible Preferred Stock	$		Common Stock (6167763)		Indirect
Series B Redeemable Convertible Preferred Stock	$		Common Stock (741107)		Indirect
Series B Redeemable Convertible Preferred Stock	$		Common Stock (22753)		Indirect

Footnotes

F1: Each share of redeemable convertible preferred stock is convertible on a one-for-2.432 basis into Common Stock at any time at the holder's election.
The redeemable convertible preferred stock will convert automatically upon the closing of the Issuer's initial public offering and has no expiration date.

F2: Shares held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein.

F3: Shares held by 436, L.P. ("436 LP"). 436, LLC ("436 LLC") is the general partner of 436 LP and may be deemed to beneficially own the shares held by 436 LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by 436 LP and, accordingly, may be deemed to beneficially own the shares held by 436 LP. Each of 436 LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein.